Addex Therapeutics Ltd (ADXN)
NASDAQ·Healthcare·Biotechnology
$6.58
-0.15%
Mkt Cap $4.76M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Dec 4, 2025 | $236.62K | $37.36K | -84.21% | — | -$1.50 | — | — | — |
| Q2 2025 Jun 20, 2025 | $236.62K | — | — | -$4.26 | -$1.33 | +68.77% | — | — |
| Q2 2025 Apr 7, 2025 | $150.00K | $1.66K | -98.89% | -$1.42 | -$1.63 | -14.71% | — | — |
| Q4 2024 Nov 22, 2024 | $150.00K | $62.72K | -58.18% | -$1.40 | -$2.77 | -97.86% | — | — |
| Q3 2024 Sep 30, 2024 | $260.00K | $128.66K | -50.52% | -$0.01 | -$1.77 | -17600.00% | — | — |
| Q2 2024 Jun 6, 2024 | $772.67K | $257.83K | -66.63% | -$0.44 | -$1.37 | -210.28% | — | — |
| Q2 2024 Apr 18, 2024 | $772.67K | $179.34K | -76.79% | -$0.66 | -$4.06 | -513.02% | — | — |
| Q4 2023 Nov 29, 2023 | $662.29K | $357.33K | -46.05% | -$4.00 | -$4.07 | -1.75% | — | — |
| Q3 2023 Aug 10, 2023 | $309.41K | $703.35K | +127.32% | -$0.83 | -$5.00 | -506.00% | — | — |
| Q2 2023 May 11, 2023 | $309.41K | $546.62K | +76.67% | -$1.03 | -$5.20 | -404.19% | — | — |
| Q1 2023 Mar 9, 2023 | — | $640.56K | — | -$0.31 | -$0.83 | -167.74% | — | — |
| Q4 2022 Nov 11, 2022 | $232.05K | $416.06K | +79.29% | -$11.20 | -$11.20 | +0.00% | — | — |
| Q3 2022 Aug 18, 2022 | $530.78K | $191.40K | -63.94% | -$11.20 | -$23.60 | -110.71% | — | — |
| Q2 2022 May 5, 2022 | $505.57K | $256.26K | -49.31% | -$10.40 | -$19.40 | -86.54% | — | — |
| Q1 2022 Mar 10, 2022 | $515.01K | $434.68K | -15.60% | -$13.20 | -$16.60 | -25.76% | — | — |
| Q4 2021 Nov 4, 2021 | $682.00K | $732.50K | +7.40% | -$14.40 | -$14.40 | +0.00% | — | — |
| Q3 2021 Aug 5, 2021 | $809.35K | $1.07M | +32.76% | -$13.00 | -$15.40 | -18.46% | — | — |
| Q2 2021 May 5, 2021 | — | $896.30K | — | -$13.00 | -$10.60 | +18.46% | — | — |
| Q1 2021 Mar 11, 2021 | — | $2.06M | — | — | -$10.60 | — | — | — |
| Q4 2020 Nov 3, 2020 | — | $29.65K | — | — | -$15.60 | — | — | — |